Open AccessMetabolic effects and safety of hydrochlorothiazide (HCTZ) in combination with olmesartan medoxomil (OLM) in stage 2 systolic hypertension (HTN)
Author(s) -
Joseph L. Izzo,
J NEUTEL,
Robert Dubiel,
F WALKER
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.177
Subject(s) - hydrochlorothiazide , medicine , olmesartan , placebo , blood pressure , urology , regimen , adverse effect , diastole , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom